Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Nov;31(12):7807-7819.
doi: 10.1245/s10434-024-16158-z. Epub 2024 Sep 7.

Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis

Kei Kobayashi  1   2 , Kenichiro Toritani  1 , Hideaki Kimura  3 , Jun Kawashima  1   2 , Koki Goto  1 , Yusuke Suwa  4 , Mayumi Ozawa  2 , Asushi Ishibe  2 , Jun Watanabe  2   4 , Itaru Endo  2
Affiliations
Comparative Study

Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis

Kei Kobayashi et al. Ann Surg Oncol. 2024 Nov.

Abstract

Background: Clinicopathological differences exist between ulcerative colitis-associated colorectal cancer (UC-CRC) and sporadic colorectal cancer (S-CRC). However, differences in the prognosis remain controversial, and the reason for these differences remains unclear. We therefore assessed the differences between patients with UC-CRC and S-CRC.

Patients and methods: This was a matched-pair analysis of the clinicopathological characteristics and prognosis of patients with UC-CRC and S-CRC who underwent colorectal resection between January 2000 and December 2021 at two institutions. Patients were matched according to age, sex, date of surgery, tumor location, and Union for International Cancer Control (UICC) stage.

Results: A total of 5992 patients underwent surgery for CRC at the two institutions, and 288 patients (48 with UC-CRC and 240 with S-CRC) were matched in this study. Patients with UC-CRC underwent more invasive surgery and had a longer operative time than those with S-CRC, but there was no marked difference in postoperative complications or perioperative mortality. Long-term outcomes showed a similar 5-year overall survival (OS) for UC-CRC and S-CRC (86.5% versus 88.8%, p = 0.742); however, in stage 3 patients, patients with UC-CRC had a poorer 5-year OS than those with S-CRC (51.4% versus 83.8%, p = 0.032). The first recurrence sites in stage 3 UC-CRC were peritoneal dissemination followed by the bones, while those in S-CRC were the liver and pulmonary system.

Conclusions: Despite no significant differences in surgical outcomes, patients with UC-CRC had a poorer prognosis than those with S-CRC at stage 3. The recurrence patterns in UC-CRC differed from those in S-CRC, suggesting a possible prognostic difference.

Keywords: Prognosis; Recurrence patterns; Sporadic colorectal cancer; Ulcerative colitis; Ulcerative colitis-associated colorectal cancer.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(2):313–21. https://doi.org/10.1053/j.gastro.2016.10.020 . - DOI - PubMed
    1. Jess T, Horvath-Puho E, Fallingborg J, Rasmussen HH, Jacobsen BA. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: A Danish population-based cohort study. Am J Gastroenterol. 2013;108(12):1869–76. https://doi.org/10.1038/ajg.2013.249 . - DOI - PubMed
    1. Kappelman MD, Farkas DK, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12(2):265–73. https://doi.org/10.1016/j.cgh.2013.03.034 . - DOI - PubMed
    1. Hrabe JE, Byrn JC, Button AM, Zamba GK, Kapadia MR, Mezhir JJ. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome. J Surg Oncol. 2014;109(2):117–21. https://doi.org/10.1002/jso.23465 . - DOI - PubMed
    1. Gearhart SL, Nathan H, Pawlik TM, Wick E, Efron J, Shore AD. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: A Surveillance Epidemiology and End Results Medicare study. Dis Colon Rectum. 2012;55(3):270–7. https://doi.org/10.1097/DCR.0b013e318242620f . - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources